Precigen (PGEN) Non-Current Deferred Tax Liability (2015 - 2024)

Precigen (PGEN) reported Non-Current Deferred Tax Liability of $1.3 million for Q4 2024, down 88.39% year-over-year from $10.9 million in Q1 2024, and up 1328.09% quarter-over-quarter from $89000.0 in Q3 2024.

Precigen (PGEN) Non-Current Deferred Tax Liability (2015 - 2024) Analysis & Trends

Precigen (PGEN) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $1.3 million in Q4 2024.

  • Non-Current Deferred Tax Liability for Q4 2024 came in at $1.3 million, down 88.39% year-over-year; the trailing twelve-month figure through Dec 2024 was $1.3 million (down 88.39% YoY), and the FY2024 annual result was $1.3 million, down 88.39% from the prior year.
  • Non-Current Deferred Tax Liability advanced to $1.3 million in Q4 2024 per PGEN's latest filing, from $89000.0 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $18.5 million in Q4 2021 and troughed at $77000.0 in Q2 2024.
  • A 5-year average of $3.9 million and a median of $2.4 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability jumped 383.69% in 2023, then plunged 96.47% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $12.6 million in 2020, then soared by 47.0% to $18.5 million in 2021, then plunged by 87.8% to $2.3 million in 2022, then jumped by 383.69% to $10.9 million in 2023, then tumbled by 88.39% to $1.3 million in 2024.
  • Business Quant data shows PGEN's Non-Current Deferred Tax Liability at $1.3 million in Q4 2024, $89000.0 in Q3 2024, and $77000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Precigen 1.32 Bn 1.32 Bn 20.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 1.27 Mn
Dec 31, 2024 1.27 Mn
Sep 30, 2024 89,000.00
Sep 30, 2024 89,000.00
Jun 30, 2024 77,000.00
Jun 30, 2024 77,000.00
Mar 31, 2024 1.78 Mn
Mar 31, 2024 1.78 Mn
Dec 31, 2023 10.95 Mn
Dec 31, 2023 10.95 Mn
Sep 30, 2023 2.13 Mn
Sep 30, 2023 2.13 Mn
Jun 30, 2023 2.18 Mn
Jun 30, 2023 2.18 Mn
Mar 31, 2023 2.24 Mn
Mar 31, 2023 2.24 Mn
Dec 31, 2022 2.26 Mn
Dec 31, 2022 2.26 Mn
Sep 30, 2022 2.09 Mn
Sep 30, 2022 2.09 Mn